# Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation Strategy

> **NCT04556578** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 2 (actual)

## Conditions studied

- Acue Respiratory Distress Syndrome

## Interventions

- **PROCEDURE:** High-flow extracorporeal CO2 removal

## Key facts

- **NCT ID:** NCT04556578
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-16
- **Primary completion:** 2023-10-26
- **Final completion:** 2023-10-26
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** change in current practice in intensive care, few inclusions achievable
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04556578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04556578, "Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation Strategy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04556578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*